RedHot Diagnostics AB is a biotechnology company based in Södertälje that specializes in the development of diagnostic products. The company focuses on therapeutic drug monitoring, providing innovative solutions that enhance the accuracy and reliability of diagnostic testing. Among its product offerings are tests for Phosphatidylethanol (PEth), which is used to assess alcohol consumption, and Tamoxifen testing solutions, which are important in the treatment of breast cancer.
In addition to these products, RedHot Diagnostics AB features Methylmalonic Acid (MMA) testing, which is relevant for diagnosing vitamin B12 deficiency. The company also offers the rhelise™ kit, designed to facilitate various diagnostic applications. With a commitment to quality and innovation, RedHot Diagnostics AB is supported by an experienced team in the diagnostics field, ensuring that they stay at the forefront of advancements in this area. The company regularly updates its stakeholders on news and developments related to its products and services.